Fenofibrate
Back to searchMolecule Structure
Scientific Name
Fenofibrate
Description of the Drug
Fenofibrate is a peroxisome proliferator receptor alpha activator used to lower LDL-C, total-C, triglycerides, and Apo B, while increasing HDL-C in hypercholesterolemia, dyslipidemia, and hypertriglyceridemia.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01039
http://www.drugbank.ca/drugs/DB01039
Brand Name(s)
Antara, Antara (micronized), Fenofibrate, Fenofibrate (micronized), Fenogal, Fenoglide, Lipantil, Lipantil micro 200, Lipantil micro 267, Lipantil micro 67, Lipidil, Lipofen, Supralip 160, Tricor, Tricor (micronized), Triglide
Company Owner(s)
Cipla Ltd, Invagen Pharmaceuticals Inc, Dr Reddys Laboratories Sa, Mankind Pharma Ltd, Abbvie Inc, Rhodes Pharmaceuticals Lp, Mylan Pharmaceuticals Inc, Amneal Pharmaceuticals Llc, Impax Laboratories Inc, Prinston Pharmaceutical Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Peroxisome proliferator-activated receptor alpha | SINGLE PROTEIN | AGONIST | CHEMBL239 |
Clinical Trial(s)
Unichem Links
| Atlas | fenofibrate | ||||||
| SureChEMBL | SCHEMBL4670 | ||||||
| PharmGKB | PA449594 | ||||||
| Human Metabolome Database | HMDB0015173 | ||||||
| DrugBank | DB01039 | ||||||
| PubChem: Thomson Pharma | 14901407 | ||||||
| PubChem | 3339 | ||||||
| Mcule | MCULE-9460650238 | ||||||
| LINCS | LSM-3107 | ||||||
| Nikkaji | J10.021H | ||||||
| BindingDB | 50085042 | ||||||
| EPA CompTox Dashboard | DTXSID2029874 | ||||||
| DrugCentral | 1152 | ||||||
| Brenda | 6805 | 132787 | |||||
| ChemicalBook | CB8266802 | ||||||
| Guide to Pharmacology | 7186 | ||||||
| rxnorm | ANTARA | FENOFIBRATE | LIPOFEN | FENOFIBRATE MICRONIZED | TRIGLIDE | FENOGLIDE | TRICOR |
| PubChem: Drugs of the Future | 22395205 | ||||||
| KEGG Ligand | C07586 | ||||||
| ChEBI | 5001 | ||||||
| ZINC | ZINC000000584092 |
